Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$499.71 -4.25 (-0.84%)
At close: Oct 1, 2026 · 4:00 PM EDT

Madrigal Pharmaceuticals (MDGL) Accumulated Expenses (2010 - 2026)

Updated

Madrigal Pharmaceuticals (MDGL) recorded Accumulated Expenses of $338.66 million in Q2 2026, up 115.0% from $157.48 million a year earlier and up 22.8% from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Accumulated Expenses (2010 - 2026) Analysis & Trends

At the end of FY2025, Madrigal Pharmaceuticals reported Accumulated Expenses of $260.39 million, up 108.8% from FY2024.

  • Annual Accumulated Expenses has a five-year compound annual growth rate of 41.9% (FY2020 to FY2025).
  • Across earlier years, Accumulated Expenses came in at $124.7 million in FY2024 (+38.6%), $89.98 million in FY2023 (-1.6%), $91.46 million in FY2022 (+66.1%) and $55.05 million in FY2021 (+21.7%).
  • Quarterly Accumulated Expenses has ranged from $53.44 million in Q1 2022 to $345.38 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Accumulated Expenses has increased for ten consecutive quarters, with growth averaging 84.7% over the last eight quarters.
  • Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 163.6% in Q3 2025, against a decline of 1.6% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $275.76 million (Q1 2026), $260.39 million (Q4 2025) and $345.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Madrigal Pharmaceuticals 14.69 Bn 10.94 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 338.66 Mn
Mar 31, 2026 275.76 Mn
Dec 31, 2025 260.39 Mn
Sep 30, 2025 345.38 Mn
Jun 30, 2025 157.48 Mn
Mar 31, 2025 124.17 Mn
Dec 31, 2024 124.70 Mn
Sep 30, 2024 131.00 Mn
Jun 30, 2024 115.61 Mn
Mar 31, 2024 92.27 Mn
Dec 31, 2023 89.98 Mn
Sep 30, 2023 82.61 Mn
Jun 30, 2023 81.76 Mn
Mar 31, 2023 85.57 Mn
Dec 31, 2022 91.46 Mn
Sep 30, 2022 79.60 Mn
Jun 30, 2022 71.84 Mn
Mar 31, 2022 53.44 Mn
Dec 31, 2021 55.05 Mn
Sep 30, 2021 58.50 Mn
API Access

Madrigal Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MDGL&period=max&api_key=YOUR_API_KEY